DAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients.

Affiliation auteurs!!!! Error affiliation !!!!
TitreDAROL: DARolutamide ObservationaL study patients in nonmetastatic castration-resistant prostate cancer (nmCRPC) patients.
Type de publicationJournal Article
Year of Publication2020
AuteursYu EY, Pieczonka CMichael, Briganti A, Murphy DG, Lebret T, Luz M, Suzuki H, Thiery-Vuillemin A, Ortiz JA, Guan R, Armstrong AJ
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume38
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X